T. Rowe Price Investment Management
OM icon

T. Rowe Price Investment Management’s Outset Medical OM Stock Holding History

T. Rowe Price Investment Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73
Closed -$1K – 851
2025
Q4 		$1K Sell
73
-2,326
-97% -$20K ﹤0.01% 890
2025
Q3 		$34K Sell
2,399
-1,621,137
-100% -$25.3M ﹤0.01% 667
2025
Q2 		$31.2M Buy
1,623,536
+20,480
+1% +$320K 0.02% 449
2025
Q1 		$17.7M Buy
+1,603,056
New +$19.1M 0.01% 528
2024
Q1 		– Sell
-211,116
Closed -$17.1M – 650
2023
Q4 		$17.1M Sell
211,116
-50
-0% -$4.07K 0.01% 494
2023
Q3 		$34.5M Hold
211,166
– – 0.02% 418
2023
Q2 		$69.3M Sell
211,166
-8,444
-4% -$2.58M 0.05% 321
2023
Q1 		$60.6M Sell
219,610
-15,048
-6% -$5.52M 0.04% 338
2022
Q4 		$90.9M Buy
234,658
+23,116
+11% +$6.52M 0.07% 273
2022
Q3 		$50.5M Buy
+211,542
New +$56.6M 0.04% 348

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

T. Rowe Price Investment Management's OM Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Outset Medical (OM) in Q1 2026, closing a stake of 73 shares — an estimated $1K sold.

T. Rowe Price Investment Management first reported a position in OM in Q3 2022 and held it in 10 quarters. The position peaked at $90.9M in Q4 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 73 Outset Medical shares in Q1 2026, an estimated $1K.
  • T. Rowe Price Investment Management first reported a position in Outset Medical in Q3 2022 and held it in 10 quarters.
  • T. Rowe Price Investment Management's Outset Medical position peaked at $90.9M in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.